TIA Management: Should TIA Patients Be Admitted? Should TIA Patients Get Combination Antiplatelet Therapy?

Overview

Journal Neurohospitalist

Publisher Sage Publications

Date 2015 Aug 20

PMID 26288673

Citations 4

Authors

Christina Mijalski

Brian Silver

Affiliations

Soon will be listed here.

Abstract

Transient ischemic attack (TIA) has gained increasing attention over the last 2 decades with the realization that the condition is common, portends potentially serious consequences, and, when identified early, can be evaluated and treated to modify future risk. In this review, we examine the issues of whether all TIA patients need admission and whether such patients should receive short-term dual antiplatelet therapy. Not all patients require admission if evaluation and treatment are done promptly. There may be a role for dual antiplatelet therapy, but the results of further clinical trials will help provide better clarity on which patients are the best candidates for this treatment.

Citing Articles

Insight from imaging on plaque vulnerability: similarities and differences between coronary and carotid arteries-implications for systemic therapies.

Cademartiri F, Balestrieri A, Cau R, Punzo B, Cavaliere C, Maffei E Cardiovasc Diagn Ther. 2020; 10(4):1150-1162.

PMID: 32968666 PMC: 7487399. DOI: 10.21037/cdt-20-528.

Uncertainty as a Key Influence in the Decision To Admit Patients with Transient Ischemic Attack.

Homoya B, Damush T, Sico J, Miech E, Arling G, Myers L J Gen Intern Med. 2018; 34(9):1715-1723.

PMID: 30484102 PMC: 6712185. DOI: 10.1007/s11606-018-4735-9.

Management, prognosis and predictors of unfavourable outcomes in patients newly hospitalized for transient ischemic attack: a real-world investigation from Italy.

Corrao G, Rea F, Merlino L, Mazzola P, Annoni F, Annoni G BMC Neurol. 2017; 17(1):12.

PMID: 28103824 PMC: 5248532. DOI: 10.1186/s12883-017-0796-3.

The Role of Omega-3 Polyunsaturated Fatty Acids in Stroke.

Bu J, Dou Y, Tian X, Wang Z, Chen G Oxid Med Cell Longev. 2016; 2016:6906712.

PMID: 27433289 PMC: 4940554. DOI: 10.1155/2016/6906712.

References

Joshi J, Ouyang B, Prabhakaran S . Should TIA patients be hospitalized or referred to a same-day clinic?: a decision analysis. Neurology. 2011; 77(24):2082-8. DOI: 10.1212/WNL.0b013e31823d763f. View

. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet. 1996; 348(9038):1329-39. DOI: 10.1016/s0140-6736(96)09457-3. View

Amarenco P, Bogousslavsky J, Callahan 3rd A, Goldstein L, Hennerici M, Rudolph A . High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med. 2006; 355(6):549-59. DOI: 10.1056/NEJMoa061894. View

Asimos A, Johnson A, Rosamond W, Price M, Rose K, Catellier D . A multicenter evaluation of the ABCD2 score's accuracy for predicting early ischemic stroke in admitted patients with transient ischemic attack. Ann Emerg Med. 2009; 55(2):201-210.e5. DOI: 10.1016/j.annemergmed.2009.05.002. View

Durrani-Tariq S, Eskin B, Allegra J . Admission rates of ED patients with transient ischemic attack have increased since 2000. Am J Emerg Med. 2013; 31(9):1349-51. DOI: 10.1016/j.ajem.2013.06.004. View

Amarenco P, Labreuche J, Lavallee P . Patients with transient ischemic attack with ABCD2 <4 can have similar 90-day stroke risk as patients with transient ischemic attack with ABCD2 ≥4. Stroke. 2011; 43(3):863-5. DOI: 10.1161/STROKEAHA.111.636506. View

Wang Y, Wang Y, Zhao X, Liu L, Wang D, Wang C . Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med. 2013; 369(1):11-9. DOI: 10.1056/NEJMoa1215340. View

Giles M, Albers G, Amarenco P, Arsava M, Asimos A, Ay H . Addition of brain infarction to the ABCD2 Score (ABCD2I): a collaborative analysis of unpublished data on 4574 patients. Stroke. 2010; 41(9):1907-13. DOI: 10.1161/STROKEAHA.110.578971. View

Giugliano R, Ruff C, Braunwald E, Murphy S, Wiviott S, Halperin J . Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2013; 369(22):2093-104. DOI: 10.1056/NEJMoa1310907. View

10.

Usman M, Notaro L, Nagarakanti R, Brahin E, Dessain S, Gracely E . Combination antiplatelet therapy for secondary stroke prevention: enhanced efficacy or double trouble?. Am J Cardiol. 2009; 103(8):1107-12. DOI: 10.1016/j.amjcard.2009.01.003. View

11.

Benavente O, Hart R, McClure L, Szychowski J, Coffey C, Pearce L . Effects of clopidogrel added to aspirin in patients with recent lacunar stroke. N Engl J Med. 2012; 367(9):817-25. PMC: 4067036. DOI: 10.1056/NEJMoa1204133. View

12.

Hackam D, Kapral M, Wang J, Fang J, Hachinski V . Most stroke patients do not get a warning: a population-based cohort study. Neurology. 2009; 73(13):1074-6. PMC: 2906182. DOI: 10.1212/WNL.0b013e3181b9c8e5. View

13.

Martinez-Martinez M, Martinez-Sanchez P, Fuentes B, Cazorla-Garcia R, Ruiz-Ares G, Correas-Callero E . Transient ischaemic attacks clinics provide equivalent and more efficient care than early in-hospital assessment. Eur J Neurol. 2012; 20(2):338-43. DOI: 10.1111/j.1468-1331.2012.03858.x. View

14.

Nguyen-Huynh M, Johnston S . Is hospitalization after TIA cost-effective on the basis of treatment with tPA?. Neurology. 2005; 65(11):1799-801. DOI: 10.1212/01.wnl.0000187067.93321.fa. View

15.

Yusuf S, Zhao F, Mehta S, Chrolavicius S, Tognoni G, Fox K . Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 2001; 345(7):494-502. DOI: 10.1056/NEJMoa010746. View

16.

Chalela J, Kidwell C, Nentwich L, Luby M, Butman J, Demchuk A . Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: a prospective comparison. Lancet. 2007; 369(9558):293-8. PMC: 1859855. DOI: 10.1016/S0140-6736(07)60151-2. View

17.

Lee M, Saver J, Hong K, Rao N, Wu Y, Ovbiagele B . Risk-benefit profile of long-term dual- versus single-antiplatelet therapy among patients with ischemic stroke: a systematic review and meta-analysis. Ann Intern Med. 2013; 159(7):463-70. DOI: 10.7326/0003-4819-159-7-201310010-00006. View

18.

Sacco R, Diener H, Yusuf S, Cotton D, Ounpuu S, Lawton W . Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med. 2008; 359(12):1238-51. PMC: 2714259. DOI: 10.1056/NEJMoa0805002. View

19.

Diener H, Bogousslavsky J, Brass L, Cimminiello C, Csiba L, Kaste M . Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet. 2004; 364(9431):331-7. DOI: 10.1016/S0140-6736(04)16721-4. View

20.

Chimowitz M, Lynn M, Derdeyn C, Turan T, Fiorella D, Lane B . Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med. 2011; 365(11):993-1003. PMC: 3552515. DOI: 10.1056/NEJMoa1105335. View